Evaluation of intervention strategies for subclinical and clinical mastitis

Similar documents
MASTITIS CASE MANAGEMENT

Milk Quality Management Protocol: Fresh Cows

Minna Koivula & Esa Mäntysaari, MTT Agrifood Research Finland, Animal Production Research, Jokioinen, Finland

The mastitis situation in Canada where do you stand?

2012 Indiana Regional Dairy Meetings. Purdue University College of Veterinary Medicine Dr. Jon Townsend Dairy Production Medicine

Mastitis: Background, Management and Control

Mastitis MANAGING SOMATIC CELLS COUNTS IN. Somatic Cell Count Are Affected by. Somatic Cells are NOT Affected by:

Veterinaria.com.pt 2009; Vol. 1 Nº 1: e13 (publicação inicial em Julho de 2008) Disponível em

, Pamela L. Ruegg

Using SCC to Evaluate Subclinical Mastitis Cows

Section 2: KPI Results for the year ending 31/08/2017

Gina M Pighetti & Raul Almeida. University of Tennessee

Options for Handling Mastitis during Lactation in Modern Dairy Farms

Premiums, Production and Pails of Discarded Milk How Much Money Does Mastitis Cost You? Pamela Ruegg, DVM, MPVM University of Wisconsin, Madison

Last 2-3 months of lactation

Walter M. Guterbock, DVM, MS Veterinary Medicine Teaching and Research Center University of California, Davis

MASTITIS DNA SCREENING

MILK COMPOSITIONAL CHANGES DURING MASTITIS

Decision tree analysis of treatment strategies for mild and moderate cases of clinical mastitis occurring in early lactation

Mastitis cows and immunization

How to Decrease the Use of Antibiotics in Udder Health Management

Interpretation of Bulk Tank Milk Results

Bulk Milk Data and Udder Health

Milk quality & mastitis - troubleshooting, control program

Using DHIA and bacteriology to investigate herd milk quality problems.

Presented at Central Veterinary Conference, Kansas City, MO, August 2013; Copyright 2013, P.L Ruegg, all rights reserved

Dairy/Milk Testing Report Detecting Elevated Levels of Bacteria in Milk-On-Site Direct- From-The-Cow Within Minutes as Indicator of Mastitis

Update on Staphylococcus aureus Mastitis. John R. Middleton College of Veterinary Medicine, University of Missouri, Columbia

Management Practices and Intramammary Infections: New Ideas for an Old Problem

Outline MILK QUALITY AND MASTITIS TREATMENTS ON ORGANIC 2/6/12

Emerging Mastitis Threats on the Dairy Pamela Ruegg, DVM, MPVM Dept. of Dairy Science

Interpretation and Use of Laboratory Culture Results and the Characteristics of Various Mastitis Pathogens

Finnzymes Oy. PathoProof Mastitis PCR Assay. Real time PCR based mastitis testing in milk monitoring programs

Sources of Different Mastitis Organisms and Their Control

Cepravin and Combination Dry Cow Therapy Trial Work

DeLaval Cell Counter ICC User Strategies Guide

Quality Milk on Pasture Based Dairy Farms. Scott E. Poock, DVM University of Missouri Clinical Assistant Professor DABVP Beef and Dairy Cattle

Effect of omitting post-milking teat disinfection on the mastitis infection rate of dairy cows over a full lactation

Practical Strategies for Treating Mastitis Pamela L. Ruegg, DVM, MPVM University of Wisconsin, Madison

Rate of transmission: A major determinant of the cost of clinical mastitis

Controlling Contagious Mastitis

Interpretation and Use of Laboratory Culture Results and the Characteristics of Various Mastitis Pathogens

Economics of mastitis. Kirsten Huijps and Henk Hogeveen

Interpretation of results from milk samples tested for mastitis bacteria with Mastit 4 qpcr test from DNA Diagnostic

MASTITIS. Therefore, mastitis is an inflammation of the mammary gland.

LOOKING FOR PROFITS IN MILK QUALITY

TEAT DIP- POST DIP- PRE DIP- STRIPING

Trouble-Shooting a Mastitis Problem Herd 1

Best practice guide for on-farm mastitis control

Summary. Table 1. Estimated infection prevalence and losses in milk production associated with elevated bulk tank somatic cell counts.

Validation of the PathoProof TM Mastitis PCR Assay for Bacterial Identification from Milk Recording Samples

Dr. Michelle Arnold, DVM DABVP (Food Animal) Ruminant Extension Veterinarian University of Kentucky Veterinary Diagnostic Laboratory

Influence of Management Techniques on the Levels of Mastitis in an Organic Dairy Herd Mastitis management in organic herd

Proper Dry-Off Procedures to Prevent New Infections and Cure Existing Cases of Mastitis. Stephen C. Nickerson University of Georgia

Genetic parameters for pathogen specific clinical mastitis in Norwegian Red cows

A PRACTISING VETS APPROACH TO THE HIGH CELL COUNT HERD

A Partial Budget Model to Estimate Economic Benefits of Lactational Treatment of Subclinical Staphylococcus aureus Mastitis

GHI-Thailand Dairy farming in Chiang Mai, Thailand. Khwanchai Kreausukon Faculty of Veterinary Medicine Chiang Mai University

Prototheca Mastitis in Dairy Cows

Mastitis and On-Farm Milk Cultures - A Field Study - Part 1

S. P. Oliver, R. A. Almeida, B. E. Gillespie, S. J. Ivey, H. Moorehead, P. Lunn, H. H. Dowlen, D. L. Johnson, and K. C. Lamar

Milk Quality Evaluation Tools for Dairy Farmers

Heifer Mastitis Management Strategies S.C. Nickerson, UGA,

Association between teat skin colonization and intramammary infections with Staphylococcus aureus and Streptococcus agalactiae

Udder Health in an International Perspective

F-MC-2: Dealing with Streptococcus agalactiae Mastitis

MILK QUALITY PROGRAMS FOR TRANSITION COWS AND HEIFERS. Leo Timms Iowa State University, Ames IA

Field Efficacy of J-VAC Vaccines in the Prevention of Clinical Coliform Mastitis in Dairy Cattle

New York State Cattle Health Assurance Program Fact Sheet Udder Health Herd Goals

Milking behaviour in dairy cows naturally infected with clinical mastitis

Mastitis Reminders and Resources LAURA SIEGLE EXTENSION AGENT VIRGINIA COOPERATIVE EXTENSION AMELIA COUNTY

BIOSECURITY ON DAIRIES... ARE WE DOING ENOUGH?

Strep. ag.-infected Dairy Cows

The Uncommon. Bacillus cereus Clost. Perfringens Nocardia spp. Mycoplasma spp. Moulds and yeasts Pseudomonas spp.

USING MANURE SOLIDS AS BEDDING Final Report. CORNELL WASTE MANAGEMENT INSTITUTE Ithaca, NY

A New Index for Mastitis Resistance

TECHNOTE 14. Decide dry cow management strategy DRYING OFF

TREATMENT DECISIONS FOR MILD AND MODERATE CASES OF CLINICAL MASTITIS. Carolina Pinzón-Sánchez

Milking Management II - Mastitis 1

Institut for Produktionsdyr og Heste

Selective Dry Cow Therapy

The Bimeda Guide to Selective Dry Cow Therapy

cure was 0.79 for ceftiofur-treated cows and 0.76 for control-treated cows, whereas the overall bacteriological

Subclinical mastitis in small ruminants: prevalence, comparative aspects and prevention

Innovation in Mastitis Treatment

Understanding the Basics of Mastitis

THIS ARTICLE IS SPONSORED BY THE MINNESOTA DAIRY HEALTH CONFERENCE.

Influence of Experimentally- induced clinical mastitis on Reproductive Performance of Dairy Cattle

Prevention of clinical and subclinical mastitis

Mastitis: The Canadian Perspective

Transmission dynamics of Staphylococcus aureus within two Danish dairy cattle herds

MATERIALS AND METHODS

Mastitis Reports in Dairy Comp 305

Mastitis Management and SCC Control in Once a Day Herds. Don Crowley- Teagasc

Economic effects of bovine mastitis and mastitis management: A review

Mastitis Prevention and Cure Rates in Heifers Treated with Spectramast Dry Cow Therapy and/or Orbeseal Dry Cow Teat Sealant

April Boll Iowa State University. Leo L. Timms Iowa State University. Recommended Citation

Somatic Cell Count as an Indicator of Subclinical Mastitis. Genetic Parameters and Correlations with Clinical Mastitis

RISKS, REALITIES AND RESPONSIBILITIES ASSOCIATED WITH MASTITIS TREATMENTS

Ren Tip # 84 11/6/15

Transcription:

Evaluation of intervention strategies for subclinical and clinical mastitis CPH Cattle seminar, 31. October 2018 Maya Gussmann, Wilma Steeneveld, Carsten Kirkeby, Henk Hogeveen, Michael Farre, Tariq Halasa

Objective Identify cost-effective intervention strategies for subclinical and clinical mastitis 2

The model: Simulating a dairy herd Lactating cows Dry cows Heifers Calves Calving area 3

The model: Simulating IMI S. agalactiae Opportunistic pathogens Contagious pathogens S. aureus S. uberis Environmental pathogens E. coli S. uberis 4

The model: Simulating IMI 5

The model: Simulating consequences of IMI Somatic Cell Count Milk yield Treatment of clinical Dry cow treatment Culling probability 6

Simulating clinical IMI interventions 3 day intramammary treatment Reactive culling: Testing before treatment, estimate recovery probability, cull cows with low probability (<50%) Testing before treatment, estimate recovery probability, cull cows with low probability (<75%), don t cull high producing cows 7

Simulating subclincial and clinical IMI interventions 3 intervention strategies for clinical IMI Combined with intervention measures for subclinical IMI: Testing of cows after 2 high SCC, after 1 month cull still infected cows Cull bottom 25%, treat rest Treat top 25% for 5 days, treat rest for 3 days 8

Simulating subclinical and clinical IMI interventions Treatment: Strategy Gross income Clinical IMI Subclinical IMI Treatment days Culled cows 3 days Cull cows with low probability for cure But don t cull high producers Herd 1 (S. aureus) Basic3 187,666 42 136 123 16 CullBottom 200,491 27 122 149 45 TreatTopLonger 201,029 27 122 158 43 Before50 196,995 30 111 47 24 CullBottom 206,342 14 83 86 34 TreatTopLonger 205,975 14 84 92 35 notculltop 196,704 32 113 32 29 CullBottom 205,383 16 87 76 40 TreatTopLonger 204,240 15 85 79 39 CullBottom Cull bottom 25%, treat others TreatTopLonger Treat top 25% for 5 days instead of 3 9

Simulating subclinical and clinical IMI interventions Treatment: Strategy Gross income Clinical IMI Subclinical IMI Treatment days Culled cows 3 days Cull cows with low probability for cure But don t cull high producers Herd 1 (S. aureus) Basic3 187,666 42 136 123 16 CullBottom 200,491 27 122 149 45 TreatTopLonger 201,029 27 122 158 43 Before50 196,995 30 111 47 24 CullBottom 206,342 14 83 86 34 TreatTopLonger 205,975 14 84 92 35 notculltop 196,704 32 113 32 29 CullBottom 205,383 16 87 76 40 TreatTopLonger 204,240 15 85 79 39 CullBottom Cull bottom 25%, treat others TreatTopLonger Treat top 25% for 5 days instead of 3 10

Simulating subclinical and clinical IMI interventions Treatment: Strategy Gross income Clinical IMI Subclinical IMI Treatment days Culled cows 3 days Cull cows with low probability for cure But don t cull high producers Herd 1 (S. aureus) Basic3 187,666 42 136 123 16 CullBottom 200,491 27 122 149 45 TreatTopLonger 201,029 27 122 158 43 Before50 196,995 30 111 47 24 CullBottom 206,342 14 83 86 34 TreatTopLonger 205,975 14 84 92 35 notculltop 196,704 32 113 32 29 CullBottom 205,383 16 87 76 40 TreatTopLonger 204,240 15 85 79 39 CullBottom Cull bottom 25%, treat others TreatTopLonger Treat top 25% for 5 days instead of 3 11

Simulating subclinical and clinical IMI interventions Treatment: Strategy Gross income Clinical IMI Subclinical IMI Treatment days Culled cows 3 days Cull cows with low probability for cure Herd 2 (S. agalactiae) Basic3 155,170 21 130 62 22 CullBottom 200,333 13 97 107 39 TreatTopLonger 200,494 13 96 115 38 Before50 157,690 21 126 50 24 CullBottom 200,286 13 96 104 39 TreatTopLonger 200,367 13 96 112 39 CullBottom Cull bottom 25%, treat others TreatTopLonger Treat top 25% for 5 days instead of 3 12

Simulating subclinical and clinical IMI interventions Treatment: Strategy Gross income Clinical IMI Subclinical IMI Treatment days Culled cows 3 days Cull cows with low probability for cure Herd 2 (S. agalactiae) Basic3 155,170 21 130 62 22 CullBottom 200,333 13 97 107 39 TreatTopLonger 200,494 13 96 115 38 Before50 157,690 21 126 50 24 CullBottom 200,286 13 96 104 39 TreatTopLonger 200,367 13 96 112 39 CullBottom Cull bottom 25%, treat others TreatTopLonger Treat top 25% for 5 days instead of 3 13

Simulating subclinical and clinical IMI interventions Treatment: Strategy Gross income Clinical IMI Subclinical IMI Treatment days Culled cows 3 days Cull cows with low probability for cure Herd 2 (S. agalactiae) Basic3 155,170 21 130 62 22 CullBottom 200,333 13 97 107 39 TreatTopLonger 200,494 13 96 115 38 Before50 157,690 21 126 50 24 CullBottom 200,286 13 96 104 39 TreatTopLonger 200,367 13 96 112 39 CullBottom Cull bottom 25%, treat others TreatTopLonger Treat top 25% for 5 days instead of 3 14

Conclusion Intervention strategies for clinical and subclinical IMI can cost-effectively reduce IMI incidence. Strategy should be chosen herd-specific. This comes at the price of increased antibiotic usage or culling. High culling costs may lead to less cost-effective strategies. 15

Questions? Thank you for your attention. 16